# Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

> **NCT00023283** · PHASE2 · COMPLETED · sponsor: **Yale University**

## Conditions studied

- Heroin Dependence
- Opioid-Related Disorders
- Substance Abuse, Intravenous

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT00023283
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** 2003-12
- **Final completion:** 2004-02
- **Target enrollment:** — (—)
- **Last updated:** 2020-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023283, "Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00023283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*